Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
10.08
+0.37 (3.81%)
At close: May 6, 2026, 4:00 PM EDT
9.75
-0.33 (-3.27%)
After-hours: May 6, 2026, 7:55 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $586.73 million as of May 6, 2026. Its market cap has increased by 47.03% in one year.
Market Cap
586.73M
Enterprise Value
603.99M
1-Year Change
47.03%
Ranking
Category
Stock Price
$10.08
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $586.73M, a decrease of -73.11%. That is a compound annual growth rate of -22.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 565.19M | 19.67% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 615.60M |
| Prime Medicine | 604.94M |
| Prothena Corporation | 596.74M |
| ProKidney | 596.37M |
| Entrada Therapeutics | 588.24M |
| Crescent Biopharma | 586.49M |
| Cabaletta Bio | 585.35M |
| enGene Therapeutics | 581.13M |